Fact CheckerSign in

NCT06458465Completed

Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients

Clinical Study Evaluating the Impact of Curcumin and Pentoxiphylline on Patients With Chronic Kidney Disease

Source: ClinicalTrials.gov · Last updated 28 May 2025

Brief summary (registry, in English)

The aim of the study is to evaluate the impact of turmeric and pentoxiphylline on serum levels of protein-bound uremic toxin (p-cresyl sulfate), oxidative stress biomarker level (Malonaldehyde), inflammatory biomarker level (Highly sensitive C-reactive protein). In addition to the evaluation of its effect on metabolic profile and disease progression in chronic kidney disease patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
24 May 2024
Start date
1 Oct 2023
Primary completion date
1 Sept 2024
Lead sponsor
Alexandria University
NCT number
NCT06458465

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Oct 2023 to the primary completion date, 1 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with cancer.
  • Patients with kidney stones and urinary tract infection.
  • Patients with bleeding disorder.
  • History of drug allergy to study medications.

Lab values

  • Patients with elevated level of potassium ≥ 5 mEq/L.

Other

  • Pregnant and breastfeeding women.

Who the study is looking for

  • Age ≥ 18 years old.
  • Both sexes.
  • Non-hemodialysis CKD patients (Stage III -V)
  • Patients matched in the duration of CKD.
  • Patients with albumin-to-creatinine ratio ≥ 30 mg/g.
  • Patients with serum Potassium \< 5 mEq/L

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nada Mustafa Kamel
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.